Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

Visiongain Report Claims There is Huge Potential Within the $91bn In Vitro Diagnostics (IVD) Market

This image opens in the lightbox

News provided by

Visiongain

17 Jul, 2019, 09:00 GMT

Share this article

Share toX

Share this article

Share toX

Top In Vitro Diagnostics (IVD) Companies 2019-2029

Danaher Corporation, Abbott Laboratories, Bio-Rad Laboratories, Roche, Siemens AG, Sysmex, Other Companies

LONDON, July 17, 2019 /PRNewswire/ -- The global in vitro diagnostics (IVD) market is estimated to have reached $69.2bn in 2018. The largest sector of the IVD market in 2018 was point of care diagnostics segment, generating sales of $19.4bn in 2018, which accounted for 28.0% of overall IVD sales.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 204-page report you will receive 180 charts– all unavailable elsewhere.

The 204-page report provides clear detailed insight into the leading in vitro diagnostics (IVD) companies. Discover the key drivers and challenges affecting the market.

By ordering and reading brand-new Visiongain report today you stay better informed and ready to act.

To request sample pages from this report please contact Sara Peerun at sara.peerun@visiongain.com or refer to our website: https://www.visiongain.com/report/medical-devices-leader-series-top-in-vitro-diagnostics-ivd-companies-2019-2029/#download_sampe_div

Report Scope

• In Vitro Diagnostics (IVD) revenues in 2017 and 2018 by Class:
• Point-of-Care
• Clinical Chemistry
• Immunochemistry
• Hematology
• Microbiology
• Genetic Testing
• Others

• In Vitro Diagnostics (IVD) revenue forecast for 2019, 2024 and 2029 by Class:
• Point-of-Care
• Clinical Chemistry
• Immunochemistry
• Hematology
• Microbiology
• Genetic Testing
• Others

• This report profiles and discusses the selected leading in vitro diagnostics (IVD) companies:
• Abbott Laboratories
• Arkray, Inc.
• Becton, Dickinson and Company (BD)
• bioMérieux SA
• Bio-Rad Laboratories, Inc.
• Dako (Agilent Technologies)
• Danaher Corporation
• Genomic Health
• Laboratory Corporation of America (LabCorp)
• MDxHealth
• Myriad Genetics
• QIAGEN
• Roche
• Siemens AG
• Sysmex Corporation
• Thermo Fisher Scientific
• Other companies

• This report discusses sales and recent performance analysis, key products, strengths and challenges, historical revenues, revenue forecast, market share forecast, mergers and acquisition (M&A) activity, strategic collaborations

• Analysis of factors that drive and restrain the in vitro diagnostics (IVD) market.
• Key Questions Answered by this Report:
• Who are the leading IVD manufacturers?
• What factors are driving and restraining growth for the leading IVD manufacturers?
• How have the leading IVD manufacturers performed financially in recent years?
• Which IVD manufacturers will experience revenue growth over the coming years?
• What are the strength and weakness of the leading IVD manufacturers?
• What strategies have IVD manufacturers been implementing for sales growth in recent years?

To request a report overview of this report please contact Sara Peerun at sara.peerun@visiongain.com or refer to our website: https://www.visiongain.com/report/medical-devices-leader-series-top-in-vitro-diagnostics-ivd-companies-2019-2029/

Did you know that we also offer a report add-on service? Email sara.peerun@visiongain.com to discuss any customized research needs you may have.

Companies covered in the report include:

AB SCIEX
Abbott Laboratories
AbD Serotec
Agilent Technologies
Alacris Theranostics GmbH
Alere
Amoy Diagnostics Co. Ltd
Analytical Informatics, Inc.
Arca biopharma
ARGENE
Arkray, Inc.
Astute Medical
Bayer
Beckman Coulter
Becton Dickinson
BioFire Diagnostics, LLC
BioMarin Pharmaceutical Inc.
bioMérieux
Bio-Rad Laboratories
Bristol-Myers Squibb
C. R. Bard, Inc.
Calbiotech Group of Companies
CareFusion
Carmel Pharma AB
Cartagenia
Cell Signaling Technology
Celldex Therapeutics
Cellestis Ltd.
Cellular Research
Cephalon
Cepheid
Chugai Pharmaceuticals
Clearbridge BioMedics
Constitutional Medical, Inc. (CMI)
Crescendo Bioscience
Dako
Danaher
DiaMed Holding
Diasis Diagnostik Sistemler Ticaret Ve Sanayi A.S.
DiaSorin S.p.A.
Diesse
Dionex
Eli Lilly
Epitomics
EQT
Erba Diagnostics Mannheim GmbH Group
Erba -Transasia
eScreen Inc.
EskoArtwork
European Commission (EC)
Fast Track Diagnostics (FTD)
Focus Diagnostics
Food and Drug Administration (FDA)
Furuno Electric Co., Ltd.
GenCell Biosystems
Genentech
Genetic Analysis
Genomic Health
Genzyme Genetics
GlaxoSmithKline (GSK)
GnuBIO Inc.
Grifols
Haliodx
Hologic, Inc.
Illumina, Inc.
Inostics Inc.
Institut Merieux
InterMune
Ipsogen S.A.
IRIS International
JEOL Ltd.
Johnson & Johnson
Kappa Biosystems, Inc.
Katakura Industries Co., Ltd.
Kem-En-Tec Diagnostics
Knome, Inc.
Koninklijke Philips N.V.
LabIndia
Laboratory Corporation of America (LabCorp)
Laetus
Leica Microsystems
Life Technologies
LipoScience, Inc.
Lyon Civil Hospitals
Maxmat SA
MDS
MDxHealth
Medica
Merck & Co.
Merck KGaA
Monogram Biosciences
MorphoSys AG
Myriad Genetics
Navman Wireless
Nobel Biocare
NovioGendix Holding B.V.
Oncomed
Oxford University
Pall
Pasteur Sanofi Diagnostics
PerkinElmer, Inc.
Pfizer
Phadia
Pharma Mar
Phenomenex
PreAnalytiX GmbH
Propel Labs
QIAGEN
Quest Diagnostics
Remote Diagnostic Technologies (RDT)
Roche
Rules-Based Medicine Inc.
Schering Plough
Seahorse Bioscience
Siemens AG
Siemens Healthcare GmbH
Siemens Healthineers
Sividon Diagnostics
St. Jude Medical
Sysmex
Sysmex Corporation
Sysmex Inostics GmBH
Thermo Fisher
Thermo Fisher Scientific
TOA Corporation
TOA Medical Electronics
Tocagen
Transasia Bio-Medicals Ltd.
Tulip Diagnostics Private Ltd.
Unisensor
Van Andel Research Institute
Vanadis Diagnostics, AB
Ventana
ViiV Healthcare
VSS Monitoring
XOS
X-Rite

To see a report overview please e-mail Sara Peerun on sara.peerun@visiongain.com

Related reports:

The Next Generation Sequencing Market Forecast 2019-2029

In-Vitro Diagnostics World Market 2018-2028

Global Blood Cancer Market Forecast to 2028

Global Cancer Immunotherapy Market Forecast 2019-2029

The Companion Diagnostics (CDx) Market Forecast 2018-2028

Gene Therapy R&D and Revenue Forecasts 2018-2028

Logo: https://mma.prnewswire.com/media/523989/Visiongain_Logo.jpg

Modal title

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.